Patents by Inventor Kenneth A. SCHULTZ

Kenneth A. SCHULTZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF
    Publication number: 20250049808
    Abstract: Described herein are crystalline forms of compounds that are deoxycytidine kinase (dCK) inhibitors, methods of making such crystalline forms, pharmaceutical compositions and medicaments comprising such crystalline forms, and methods of using such crystalline forms in the treatment of conditions, diseases, or disorders that would benefit from modulation of deoxycytidine kinase (dCK) activity.
    Type: Application
    Filed: August 23, 2024
    Publication date: February 13, 2025
    Inventors: David LITZINGER, Kenneth A. SCHULTZ
  • Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof
    Patent number: 11446307
    Abstract: Described herein are crystalline forms of compounds that are deoxycytidine kinase (dCK) inhibitors, methods of making such crystalline forms, pharmaceutical compositions and medicaments comprising such crystalline forms, and methods of using such crystalline forms in the treatment of conditions, diseases, or disorders that would benefit from modulation of deoxycytidine kinase (dCK) activity.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: September 20, 2022
    Assignee: TRETHERA CORPORATION
    Inventors: David Litzinger, Kenneth A. Schultz
  • CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF
    Publication number: 20220135555
    Abstract: Described herein are crystalline forms of compounds that are deoxycytidine kinase (dCK) inhibitors, methods of making such crystalline forms, pharmaceutical compositions and medicaments comprising such crystalline forms, and methods of using such crystalline forms in the treatment of conditions, diseases, or disorders that would benefit from modulation of deoxycytidine kinase (dCK) activity.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: David LITZINGER, Kenneth A. SCHULTZ
  • CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF
    Publication number: 20220133735
    Abstract: Described herein are crystalline forms of compounds that are deoxycytidine kinase (dCK) inhibitors, methods of making such crystalline forms, pharmaceutical compositions and medicaments comprising such crystalline forms, and methods of using such crystalline forms in the treatment of conditions, diseases, or disorders that would benefit from modulation of deoxycytidine kinase (dCK) activity.
    Type: Application
    Filed: November 1, 2021
    Publication date: May 5, 2022
    Inventors: David LITZINGER, Kenneth A. SCHULTZ